SEC Form D · Amendment · filed March 2, 2021
Pear Therapeutics, Inc
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Yuri Maricich · Boston, MAExecNancy Schlichting · Boston, MADirectorAndrew Schwab · Boston, MADirectorTimothy Petersen · Boston, MADirectorElena Viboch · Boston, MADirectorChristopher Guiffre · Boston, MAExecJulia Strandberg · Boston, MAExecZack Lynch · Boston, MADirectorCorey Mccann · Boston, MAExec · DirectorRonan O'Brien · Boston, MAExecAzam Pasha · Dubai, C0DirectorJohn D'Agostino · Boston, MAExec · DirectorMichael T. Willner · Westport, CTExecJamie Star · Boston, MADirectorDaniel L. Delaney · San Francisco, CAExecAION Value Add II GP LLC · New York, NYDirectorJason Fitzgerald · Boston, MADirectorMaven Fund GP Ii, LLC · LARKSPUR, CADirectorEdward T. Minskoff · Westport, CTExecRobert M. Austin · San Francisco, CAExecMichael Blitzer · New York, NYDirectorGuy Shanon · New York, NYDirectorVerena A. Lim · Singapore, U0Exec · DirectorDavid A. Baldwin · Singapore, U0DirectorChristopher E. Low · Singapore, U0ExecGeoff Ruddick · Grand Cayman, Cayman IslandsExecTim Jackson · San Diego, CADirectorCaskie Collet · San Francisco, CAExecJoseph Sherman · San Francisco, CAExecJeffrey D. Malec · CHICAGO, ILDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗